Jury Awards $8 Million in Damages for Metal Hip Replacement

March 20, 2013

A Los Angeles jury has ordered the healthcare giant Johnson & Johnson, the world’s biggest medical products maker, to pay $8 million in damages for injuries resulting from the all metal hip replacement made by DePuy, the orthopedic branch of Johnson & Johnson.

This is the first verdict and award in nearly 11,000 suits filed against the company for the DePuy metal hip replacements.

Loren Kransky, a retired prison guard, claimed the all metal ball and socket hip implant left him with crippling injuries, and the jury agreed.  The jury found the implant was defectively designed, which lead to metal poisoning and other health issues suffered by Kransky.

Johnson & Johnson pulled the product from the market about 2 years ago, but has set aside around $3 billion to cover the costs of recalling defective hip implants and law suits resulting from these implants.

This verdict sends a clear message that the claims arising from the DePuy hip implant are real and cause severe and significant damages which Johnson & Johnson will be held accountable for.

During the trial, Kransky’s lawyers demonstrated how the all metal hip implant would deteriorate and some of the metal would flake off, causing metal poisoning which led to Kransky’s health issues and could potentially have killed him.  Despite the defense bringing up Kransky’s long history of past health problems, the jury returned a verdict ordering Johnson & Johnson to pay.

The artificial hip implant was made to help with pain and mobility issues.  The hip joint was sold for more than 8 years to more than 90,000 people worldwide.  In 2008, roughly 40% of U.S. hip replacements were all metal.  By 2009 pulled from the market and Johnson & Johnson stopped manufacturing them.

If you received a metal hip implant and believe it is causing health issues, please contact The Brad Hendricks Law Firm, located in Little Rock, Arkansas, at (501) 588-0549 or toll free (866) 676-5096 today.


Injured by Yaz?

March 12, 2013

Yaz, Yasmin, Ocella Birth Control Injuries Litigation

The Brad Hendricks Law Firm wants to help if you or a loved one has been harmed by Yaz (also known as Yasmin and by its generic name "Ocella").

Originally developed and manufactured by Berlex Laboratories, these medications are referred to as "combination birth control," which contain the hormones estrogen (ethinyl estradiol) and progestin (drospirenone or "drsp"). Yasmin was approved by the Food and Drug Administration on May 11, 2001.

Bayer AG acquired Berlex Laboratories in 2006 and began marketing this product as "a "different type of birth control pill." At one point, Yaz was marketed as an effective treatment of premenstrual syndrome (PMS), but in October 2008, the FDA issued a warning letter for this deceptive claim and clarifying that the medication was only meant to help treat Premenstrual Dysphoric Disorder (PMDD) while simultaneously reducing the effects of acne. This marketing campaign was highly effective and today it is the number one birth control pill in the United States, with more than $600 million sales in 2008.

Unfortunately, this "different type of birth control pill" that was marketed as offering such additional perks, in addition to preventing pregnancy, is not without its risks. Some women might simply experience symptoms such as:

Severe Headaches

Severe allergic reactions including rash, hives, itching, difficulty breathing.

Tightness in the chest swelling of the mouth, face, lips, or tongue.


Irregular heartbeat

Symptoms of liver problems

Unusual or severe vaginal bleeding

Unusual tiredness or weakness

Vaginal irritation or discharge

Vision changes (eg, sudden vision loss, double vision)

For others, however, the risks are much higher and include the following:

Heart Attack

Cardiac Arrhythmias


Pulmonary embolism (an artery in the lung is blocked)

Blood Clots (Non-Vaginal)

Kidney Complications and Kidney Failure


Deep Vein Thrombosis (DVT)

Gallbladder Disease

Hepatic Adenomas


Sudden Death

There have been more than 50 reports of deaths filed with the FDA since 2004.

The Brad Hendricks Law Firm believes that these risks are simply unacceptable. If you or someone you love have experienced any of these symptoms after taking Yaz, Yasmin, or Ocella, you may be entitled to compensation. For a free consultation with an experienced attorney about your claim, please contact us today at (501) 588-0549 or (866) 676-5096 today!

Injured by Transvaginal Mesh/Bladder Slings to treat Pelvic Organ Prolapse or Stress Urinary Incontinence?

July 30, 2012
Little Rock, AR Transvaginal Mesh and Bladder Sling Attorneys

Transvaginal Mesh and Pelvic Organ Prolapse & Stress Urinary IncontinenceThe Brad Hendricks Law Firm is investigating claims of severe complications associated with the use of transvaginal surgical mesh and bladder slings, which have been surgically installed to treat Pelvic Organ Prolapse (“POP”) and Stress Urinary Incontinence (“SUI”).

Pelvic Organ Prolapse occur when pelvic organs drop from their normal position because the tissues and muscles of the pelvic floor are no longer able to support the organs, which the uterus and bladder.  The muscles and tissue may become torn or weakened because of childbirth or age.  For several years surgical mesh has been used to treat POP and stress urinary incontinence.

Historically, surgical mesh has been used since the 1950s to repair abdominal hernias.  In the 1970s, gynecologists incorporated surgical mesh to treat POP.  Surgical mesh has been used to treat transvaginal POP and SUI since the 1990s.

In 2008, the United States Food and Drug Administration (“FDA”) issued a Public Health Notification (“PHN”) to warn patients about adverse effects related to urogynecologic use of surgical mesh.  Between January 1, 2008, and December 31, 2010, 2,874 medical device reports (“MDR”) were submitted chronicling complaints of malfunction, injury and even death.  Of those reports, 1,503 were associated with POP, while 1,371 reports were associated with SUI repairs.  There were 3,979 reports of injury, death and malfunction between January 1, 2005, and December 31, 2010.

Unfortunately, the FDA has reported, “[m]esh-associated complications are not rare.”  Approximately 10 of women undergoing transvaginal POP repair experience vaginal mesh erosion within 12 months of surgery.  Mesh contraction, which can cause vaginal shortening, tightening, or vaginal pain is increasingly reported by patients.  Some patients require numerous follow up procedures.

Common Complications from Surgeries that Insert Transvaginal Mesh and Bladder Slings

The most common complications associate with the use of transvaginal mesh and bladder slings include the following:

Mesh erosion through the vaginal tissue
Chronic vaginal drainage
Erosion of the vaginal tissue
Feeling as though something is protruding from the vagina
Lower back pain
Pain during intercourse and Vaginal Pain not related to intercourse
Perforations of the bowel, bladder or blood vessels
Pressure or feeling of “fullness” in the lower abdomen
Reoccurrence of pelvic organ prolapse (POP) or stress urinary incontinence (SUI)
Continued urinary problems
Vaginal bleeding
Vaginal infections
Vaginal pain not related to intercourse
Vaginal scarring

The Securities and Exchange Commission has reported that approximately 47,000 women have received pelvic mesh implants.  To date, more than 600 lawsuits have been filed against manufacturers.

Call Us if You or a Loved One has Been Injured by Transvaginal Mesh used to treat POP or SUI

The Brad Hendricks Law Firm wants to know if you or a loved one has been harmed by transvaginal mesh/bladder slings used to treat Pelvic Organ Prolapse and Stress Urinary Incontinence.  Call The Brad Hendricks Law Firm today at (501) 588-0549 or (866) 676-5096 for a free consultation with an experienced team of lawyers and professionals. If you or a loved one has been harmed by this urological or gynecological use of surgical mesh, you can count us to fight to make sure you are compensated for your injuries.

Enhanced by Zemanta

FDA Approved Pradaxa Linked to Fatal Bleeds

June 15, 2012

Arkansas Pradaxa Lawyers in Little Rock - Brad Hendricks Law Firm

If you or a loved one has taken Pradaxa (dabigatran etexilate mesylate), an anticoagulant or blood thinning medication used to reduce the risk of stroke in patients with non-valvular atrial fibrillation (AF), and have suffered dangerous, life-threatening side effects such as internal bleeding or hemorrhaging, heart attack or myocardial infarction (MI), please call The Brad Hendricks Law Firm.

Pradaxa Approved by FDA in 2010 and Investigated by 2011

In 2010, the United States Food & Drug Administration (FDA) approved Pradaxa, manufactured by Boehringer Ingelheim Pharmaceuticals, Inc., as a direct thrombin inhibitor indicated to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. Its popularity soon increased due to the perception that it was easier to use and modify than warfarin, with fewer interactions.

An investigation was launched less than one year later, in September 2011, after five New Zealand patients died from internal bleeding/hemorrhaging after taking Pradaxa. Mere weeks earlier, Japanese officials had notified the manufacturer that 81 elderly patients experienced heavy bleeding/hemorrhaging from March 14 to August 11, during which time five patients died. In the United States, the FDA received approximately 3,781 adverse event reports identifying Pradaxa use in 2011 alone-more than reports associated with any other drug monitored by the FDA.

No Known Antidote for Pradaxa-Related Bleeding

The FDA announced in January 2012 that it had approved changes to the Warning and Precautions section of Pradaxa’s labeling to include the following: "Lack of a specific reversal agent; futility of using vitamin K to affect anticoagulant effect." There is no specific agent known to aid with the reversal of Pradaxa related bleeding. Vitamin K, a known antidote used to counter warfarin-related bleeding, is ineffective. The new labels also warned that Pradaxa’s anticoagulant activity and half-life are increased in patients with renal (kidney) impairment. Pradaxa was hailed as a safer alternative to traditional blood thinners like warfarin; however, warfarin bleeding may be interrupted by administering Vitamin K. Because Vitamin K is not effective to interrupt Pradaxa bleeding, the effects can be deadly. Risks increase with age, according to some reports.

Pradaxa Bleeds May be Fatal - Brad Hendricks Law Firm Although anticoagulants are known to carry some risk of bleeding, patients who have taken Pradaxa have reported potentially harmful symptoms such as:

Unusual bleeding/hemorrhaging or bruising
Unusual gum bleeding or frequent nose bleeds
Heavier-than-normal menstrual or vaginal bleeding
Uncontrolled bleeding
Pink or brown urine or red or black (tar-like) stools
Unexplained bruising or bruising that gets larger
Coughing up blood or blood clots
Vomiting blood, or vomiting a substance resembling coffee grounds
Weakness or swelling of the feet, ankles, lower legs, hands, and feet or other joint pain or swelling

The FDA cautions that those taking Pradaxa should not stop taking the medication without first consulting a trained healthcare professional, as sudden cessation of this medication may increase the risk of stroke. If you or a loved one are taking or have taken Pradaxa, and have observed or developed any symptom identified above, please contact your healthcare provider immediately. Ask your healthcare professional whether Pradaxa could be the cause of the problem.

Pradaxa Injury Help You Can Count On

We want to know about your experience with this dangerous drug whose use may lead to fatal internal bleeding or hemorrhaging. Call The Brad Hendricks Law Firm today at (501) 588-0549 or (866) 676-5096 for a free consultation with an experienced team of lawyers and professionals. If you or a loved one has been harmed by Pradaxa, you can count us to fight to make sure you are compensated for your injuries.

Fractures of the Femur Related to Fosamax

May 19, 2011

If you or a loved one has suffered a fractured femur while taking Fosamax for Osteoporosis, call The Brad Hendricks Law Firm today to speak with a member of our firm.  More information may be found on our website.

Roughly one out of five American woman over the age of fifty (50) suffer from what is the most common type of bone disease–osteoporosis.  It is characterized by thinning bone tissue and loss of bone density over time.  As bones weaken, the possibility of fractures of the bone increases.  To combat the increased risk of fractures in those suffering from osteoporosis, many physicians prescribe a group of drugs known as “bisphosphonates.”  Among this group are Fosamax, Actonel, Boniva, Atelvia, and Reclastl.  Unfortunately, osteoporosis is not limited to women alone.

The Brad Hendricks Law Firm is now accepting inquiries related to injuries caused by Fosamax—the most popular drug prescribed by physicians which, tragically, has been connected with painful and debilitating fractures of the femur, one of the strongest bones in the human body.  While manufacturers have profited from sales exceeding $3.5 billion, those injured by Fosamax and similar drugs bear the ultimate cost.

In recent years, women have reported femoral fractures that occurred as they performed what seemed to be perfectly safe activities, like walking down stairs, jumping rope, and exercising.  One woman had suffered two broken femurs. 

At The Brad Hendricks Law Firm, we believe those who have suffered painful femur fractures by Fosamax should be compensated, particularly where there is evidence that the drug actually causes the injury it is prescribed to prevent.  If you or a loved one have been prescribed Fosamax and suffered a fracture of the femur while taking Fosamax, you may be entitled to compensation from the manufacturer for medical bills, lost wages, pain and suffering, and other damages.  For a free legal consultation, please call The Brad Hendricks Law Firm today at (501) 588-0549 or (866) 676-5096.